Drug Chatter -- Tracking biopharma stock chatter

Profile for BioLineRx Ltd. (BLRX)

« Back to company index

BLRX Chatter Timeline

Stock Ticker for BLRX

Most Active Tweeters for BLRX

UserTweets
@TrelP 11
@DarrylKonas 4
@Ultra_Calls 3
@Kevin_W81 2
@noritsunagirota 2

Recent Tweets for BLRX

AmericanBanking @AmericanBanking
Bioline RX $BLRX PT Set at $4.00 by HC Wainwright https://t.co/nZAmLFwQ24 #stocks
January 17th 2018, 11:01pm
NASDAQODUK @NASDAQODUK
$BLRX BioLineRx Announces Partial Monotherapy Results from Pha… https://t.co/6etNmTI6sG
January 17th 2018, 11:01pm
HasanRT1985 @HasanRT1985
$blrx Well, the chart might explains something about the strong support level at $1.04 https://t.co/sBudWOyf6k
January 17th 2018, 5:01pm
tgtxdough @tgtxdough
JMP $BLRX findings mark first clinical data for BL-8040 in patients with metastatic pancreatic cancer continues to… https://t.co/mKxwQ7OJfD
January 17th 2018, 3:01pm
alphabetastock @alphabetastock
BioLine Rx Ltd $BLRX https://t.co/BVxXmQgz65
January 17th 2018, 2:01pm
Ultra_Calls @Ultra_Calls
$BLRX This is working guys! 1.05 wall down
January 17th 2018, 1:01pm
theBigCatalyst @theBigCatalyst
$BLRX found support at this level, very safe daytrade/swing. If volume comes and they pull that ask, this can fly
January 17th 2018, 1:01pm
dispatchtribune @dispatchtribune
Bioline RX $BLRX Given a $4.00 Price Target by HC Wainwright Analysts https://t.co/MCMfKfOueF
January 17th 2018, 1:01pm
ExplicitAdviser @ExplicitAdviser
RT @odibro: $BLRX Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer. Top line data 2H 2018 https://t.c…
January 17th 2018, 1:01pm
Ultra_Calls @Ultra_Calls
$BLRX Very Strong Bid
January 17th 2018, 11:01am
Ultra_Calls @Ultra_Calls
$BLRX This one is beautiful. Added 5K @ 1.05 Team
January 17th 2018, 11:01am
Margare30926081 @Margare30926081
Biolinerx $BLRX "Buy" Rating Reiterated by H.C. Wainwright https://t.co/TOZ0e58HbN
January 17th 2018, 11:01am
PCGAdvisory @PCGAdvisory
$BLRX BioLineRx Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer https://t.co/DqfZgCE98l
January 17th 2018, 10:01am
tymorapro @tymorapro
$BLRX: ApproachingKeyLevel- (1.00), News, 8:3Accel-, tf:1011000, ch:-2.8%, medFlt:63M, 1DyChgHi:-15%; TLM:1.1, DyVol:883T:0.4x:0.5x
January 17th 2018, 10:01am
judy_altaf @judy_altaf
$BLRX first 2 PRs Friday when Co presents data with $MRK KEYTRUDA & Genentech Tecentriq and three next week including 1 with AGI-134
January 17th 2018, 9:01am
Briefingcom @Briefingcom
$BLRX: BioLineRx announces partial monotherapy results from Phase 2a COMBAT study in pancreatic cancer; BL-8040... https://t.co/9H31nzB4Rf
January 17th 2018, 9:01am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
BioLineRx announces partial monotherapy results from Phase 2a COMBAT study in pancreatic cancer https://t.co/aXTRXSXIbg #premarket $BLRX
January 17th 2018, 8:01am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
BioLineRx announces partial monotherapy results from Phase 2a COMBAT study in pancreatic cancer https://t.co/aXTRXSG6MG #premarket $BLRX
January 17th 2018, 8:01am
MarketCurrents @MarketCurrents
BioLineRx announces partial monotherapy results from Phase 2a COMBAT study in pancreatic cancer https://t.co/PcTYFlZ9H3 #premarket $BLRX
January 17th 2018, 8:01am
NewsQuantified @NewsQuantified
$BLRX stocks boosts +5.17% after it announces results from Phase 2a study in #PancreaticCancer, #BioLineRx https://t.co/vFrxT0gouA
January 17th 2018, 7:01am
ITRADEVOL @ITRADEVOL
$BLRX 1.16 +0.08 +7.4% (Premarket) Latest News and Trading Summary All·Press Releases·Headlines https://t.co/jIJLodL3M9
January 17th 2018, 7:01am
livetraderalrt @livetraderalrt
$BLRX 12.8m ago: BioLineRx Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer https://t.co/ybq8eROCkm
January 17th 2018, 7:01am
darylmox @darylmox
RT @BioStocks: $BLRX Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer https://t.co/90zljHWVwC
January 17th 2018, 7:01am
NAS_TAQZ @NAS_TAQZ
$BLRX Reports Partial Monotherapy Results from Phase 2A COMBAT Study in Pancreatic Cancer ?????
January 17th 2018, 7:01am
ProTradersNews @ProTradersNews
$BLRX: BioLineRx Announces Partial Monotherapy Results from Phase 2a …: https://t.co/ujLH5XPful
January 17th 2018, 7:01am
BursatilBiotech @BursatilBiotech
$BLRX COMBAT Ph2 study in Pancreatic Cancer https://t.co/1NUOfNXpC7
January 17th 2018, 7:01am
StockTexts @StockTexts
$BLRX BioLineRx Ltd. SEC Filing: Form 6-K https://t.co/8D6wIsBtml
January 17th 2018, 7:01am
BioStocks @BioStocks
$BLRX Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer https://t.co/90zljHWVwC
January 17th 2018, 7:01am
odibro @odibro
$BLRX Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer. Top line data 2H 2018 https://t.co/pjz1ef2GFG
January 17th 2018, 7:01am
SwingingForward @SwingingForward
$BLRX - BioLineRx Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer
January 17th 2018, 7:01am
WatchlistN @WatchlistN
Bioline RX $BLRX Stock Price Down 0% https://t.co/ZcQtZxwTz4
January 17th 2018, 2:01am
Flyt145 @Flyt145
$BLRX. Abstract out. Looks solid! This should move north pretty good.
January 16th 2018, 7:01pm
Here2TradeHey @Here2TradeHey
$blrx biopsies shows 15-fold increase in the CD3+ population, and up to two-fold increase of CD8+ cells, in the tum… https://t.co/KB1cMTWAdA
January 16th 2018, 6:01pm
tymorapro @tymorapro
$BLRX: ApproachingKeyLevel- (1.00), tf:1000000, ch:-8.7%, 1MoLo-, medFlt:63M, 0DyChgHi:-15%; TLM:1.3, 1MoLo-, DyVol:1.77M:1.5x:1.2x
January 16th 2018, 1:01pm
Kevin_W81 @Kevin_W81
$BLRX -5% this morning, -3% last Friday Traders are selling it ahead of ASCO update Typical momentum trade sell-o… https://t.co/G47RsT4J1z
January 16th 2018, 10:01am
MarieSm76375904 @MarieSm76375904
Biolinerx LTD $BLRX Stake Raised by Bvf Inc https://t.co/ZrLTInGXYN
January 15th 2018, 7:01am
bigbluecup721 @bigbluecup721
BioLineRx Ltd. $BLRX Stock Live Analysis 04-21-2017 #pennystocks https://t.co/yuwc8rePnd
January 15th 2018, 1:01am
OlympiaReport @OlympiaReport
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Bioline RX $BLRX Stock Price https://t.co/lsoU9wFoNh
January 14th 2018, 8:01am
DHeman86 @DHeman86
Sold $BLRX even, just not really moving or going anywhere and I don't want to hold through data in case it's negative.
January 12th 2018, 11:01pm
paulslyone @paulslyone
$blrx getting a bad feeling,,, short position small but up,,, large volume not much movemet
January 12th 2018, 12:01pm
TTMTrades @TTMTrades
@LAHunt $BLRX looks like its setting up for a run to 1.34
January 12th 2018, 9:01am
TheMarketsDaily @TheMarketsDaily
Bioline RX $BLRX Sees Strong Trading Volume https://t.co/bgjgpAGyHf
January 11th 2018, 6:01pm
TrelP @TrelP
$BLRX someone is definitely loading the boat here, should see a nhod after 230 imo!
January 11th 2018, 12:01pm
FonsieTrader @FonsieTrader
$BLRX on the move
January 11th 2018, 9:01am
windham_kathryn @windham_kathryn
BioLine Rx Ltd $BLRX Reaches $1.19 Formed H&S https://t.co/S4Cl2hDG0N
January 11th 2018, 6:01am
3mexandme @3mexandme
RT @Kevin_W81: $BLRX H.C Wainwright issued buy rating with $4 price target "clear pathway to FDA approval" Other 12-month targets & rati…
January 10th 2018, 10:01pm
rogerthat191 @rogerthat191
@Half_French plus look at todays volume. Lots of eyes on this IMO $BLRX
January 10th 2018, 6:01pm
rogerthat191 @rogerthat191
$BLRX LOVE this chart going into data later this month. https://t.co/PSk36r3Azz
January 10th 2018, 6:01pm
TrelP @TrelP
$NVAX Played today kinda safe, in 1.78 out 1.95... Now I’m loaded in $BLRX for the run up into next week... I’m in at 1.14!
January 10th 2018, 5:01pm
AskGeorgeBailey @AskGeorgeBailey
RT @Rajgillishere: Accumulated $BLRX and $DERM
January 10th 2018, 4:01pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.